共 239 条
[1]
Abigerges D, 1996, ANTI-CANCER DRUG, V7, P166
[2]
AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
[3]
QUANTITATION OF DAUNORUBICIN AND ITS METABOLITES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION
[J].
JOURNAL OF CHROMATOGRAPHY,
1982, 232 (02)
:377-383
[4]
High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues
[J].
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES,
1999, 721 (02)
:271-278
[6]
ANDO S, 1986, CANCER TREAT REP, V70, P835
[7]
Catalytic inhibitors of DNA topoisomerase II
[J].
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION,
1998, 1400 (1-3)
:155-171
[9]
Mutagenic properties of topoisomerase-targeted drugs
[J].
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION,
1998, 1400 (1-3)
:213-222
[10]
Determination of plasma concentrations of epirubicin and its metabolites by high-performance liquid chromatography during a 96-h infusion in cancer chemotherapy
[J].
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS,
1996, 681 (02)
:323-329